Workflow
普洛药业: 2025年中期利润分配方案

Group 1 - The core point of the announcement is the approval of the 2025 interim profit distribution plan by the company's board, which will be submitted for shareholder approval [1] - The total profit available for distribution to shareholders for the first half of 2025 is approximately 5.24 billion yuan, while the profit available for distribution from the parent company is approximately 590.23 million yuan [1] - The proposed cash dividend is 3.4835 yuan per 10 shares, totaling approximately 400.05 million yuan to be distributed to shareholders [1][2] Group 2 - The cash dividend plan will be adjusted if there are changes in the total share capital due to share buybacks, stock incentive plans, or refinancing [2] - The cash dividend amounts for previous years are as follows: 412.41 million yuan for 2024 and 369.51 million yuan for 2023 [2] - The company has completed share buybacks totaling approximately 153.09 million yuan in the first half of 2025 [2][3] Group 3 - The distribution plan complies with relevant regulations and guidelines, ensuring legality, compliance, and reasonableness [3] - The audit committee has approved the profit distribution plan, stating it aligns with the company's long-term development and does not harm the interests of shareholders, especially minority shareholders [3]